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FusionHerpes simplex virus entry into cells requires the binding of envelope glycoprotein D (gD) to an entry
receptor. Depending on the cell, entry occurs by different mechanisms, including fusion at the cell surface or
endocytosis. Here we examined the entry mechanism through a non-HSV receptor mediated by a soluble bi-
speciﬁc adapter protein composed of recognition elements for gD and the EGF receptor (EGFR). Virus entered
into endosomes using either EGF or an EGFR-speciﬁc single chain antibody (scFv) for receptor recognition.
Infection was less efﬁcient with the EGF adapter which could be attributed to its weaker binding to a viral gD.
Infection mediated by the scFv adapter was pH sensitive, indicating that gD–EGFR bridging alone was
insufﬁcient for capsid release from endosomes. We also show that the scFv adapter enhanced infection of
EGFR-expressing tumor tissue in vivo. Our results indicate that adapters may retarget HSV infection without
drastically changing the entry mechanism.ku, Fukuoka 812–8582, Japan.
akano).
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HSV-1 entry into cells is initiated by the binding of envelope
glycoprotein D (gD) to one of several entry receptors, mainly nectin-1,
a cell adhesion molecule, and HVEM, a member of the TNF receptor
family (Campadelli-Fiume et al., 2007; Spear, 2004; Spear et al., 2000).
The route of HSV entry can vary between cells even when the same
entry receptor is used, suggesting that the membrane environment
and associated cell properties are key determinants of the entry
pathway. Vero cells expressing endogenous nectin-1 and HVEM are
infected by viral envelope fusion with the plasma membrane,
resulting in direct delivery of capsids into the cytoplasm (Spear,
1993). Chinese hamster ovary (CHO) cells are resistant to HSV-1
infection due to the absence of entry receptors, but ectopic expression
of nectin-1 or HVEM allows infection via acidifying endosomes
(Nicola et al., 2003). Virus internalization by B78H1mouse melanoma
cells also involves endocytosis, but exposure to an acidic milieu is not
required for penetration (Milne et al., 2005). In addition, a mechanism
resembling phagocytosis has been described (Clement et al., 2006).It was previously reported that replacement of the transmembrane
and cytoplasmic regions of nectin-1 ectopically expressed in baby
hamster kidney J1.1-2 cells with the corresponding regions of EGFR
switched the HSV entry pathway from a pH-independent to a pH-
dependent mechanism (Gianni et al., 2004). While entry in this study
involved virus binding to the nectin-1 ectodomain displayed on the
cell surface, we have explored the mode of HSV entry when the virus
binds to a non-HSV receptor, full-length EGFR, via a soluble bridging
molecule (adapter).
We previously reported that an adapter composed of the gD-
binding nectin-1 variable (V) domain and a single-chain antibody
(scFv) recognizing the EGFR mediated efﬁcient infection of EGFR-
transduced CHO-K1 cells that lack normal gD receptors (Nakano et al.,
2005). Here we show that adapter-mediated EGFR-dependent
infection of both J1.1-2 and CHO-K1 cells takes place by low pH-
dependent endocytosis. Thus indirect gD binding to a novel receptor
has the same effect on the viral entry mechanism into J1.1-2 cells as
direct gD interaction with chimeric nectin-1/EGFR. However, since
HSV infection of nectin-1-transduced CHO-K1 cells occurs by low pH-
dependent endocytosis, a change in entry mechanism is not
obligatory for adapter-mediated infection. We also report that
replacement of the scFv portion of the adapter with EGF weakened
the adapter–gD interaction and reduced EGFR-dependent virus entry.
Experiments to determine the effect of the scFv adapter in vivo
13K. Nakano et al. / Virology 413 (2011) 12–18demonstrated increased infection of EGFR-bearing tumor tissue. Our
results suggest that adapters do not fundamentally change the
mechanism of HSV infection and can be utilized for enhanced gene
delivery to targeted cell populations in vivo.
Results
Adapter construction
Unlike EGF, the scFv used in our previous EGFR targeting adapter is
not a signaling ligand (Gill et al., 1984), and thus it was of interest to
determinewhether replacement of the scFv with EGFwould provide an
effective adapter. As illustrated in Fig. 1A, the two adapters contained
the same gD-binding variable domain of human nectin-1 (V-nec)
followed by a spacer (S1) at the amino terminus and the same epitope
tags at the carboxyl terminus but differed in the EGFR-interacting
sequences linking these elements. Both adapters were produced by
bacterial expression as previously described (Nakano et al., 2005).
Fig. 1B shows a Coomassie-stained gel of samples of the puriﬁcation
steps. Both puriﬁed adapters were readily detected by immunoblotting
using an antibody directed against the c-Myc tag (data not shown).
HSV entry-mediating activities
The abilities of the two adapters to mediate HSV entry into CHO-
EGFR and J-EGFR cells, which lack receptors for gD but stably express
human EGFR, were examined by reporter-gene assays using a
replication-defective, dual reporter gene (lacZ and eGFP) recombinantFig. 1. Adapter structures and production. (A) Structure of the scFv and EGF adapters. V-nec,
nectin-1V-domain; S1 and S2, spacers; VL, light chain variable region of anti-EGFR
monoclonal antibody 528; VH, heavy chain variable region ofmAb 528. Both proteins have
a C-terminal c-Myc (diamond) and His6 (hexagon) tag. (B) Coomassie-stained SDS–PAGE
gels of bacterial protein samples at different stages of adapter puriﬁcation. Lanes (1, 5),
solubilized intracellular insoluble fraction (sICIS) prepared as inNakano et al., 2005; (2, 6),
Ni2+ column ﬂow-through; (3, 7), columnwash; (4, 8), column eluate; (9), refolded scFv
adapter; (10), refolded EGF adapter; (11) refolded EGF adapter, half the amount of lane 11.
Size markers (M) are in kDa.virus, QOZHG (Chen et al., 2000). Based on our previous determina-
tion that 30 μg/ml of scFv adapter is saturating for QOZHG entry into
CHO-EGFR cells at an MOI of 3 (Nakano et al., 2005), we used these
conditions to compare the entry-mediating activities of the two
adapters. Visualization of β-galactosidase (LacZ) activity at 16 h post-
infection (p.i.) showed that both adapters mediated EGFR-dependent
infection of CHO cells (Fig. 2A) and J cells (Fig. 2B). Quantitative
measurement of LacZ activity by ONPG assay (see Materials andFig. 2. Comparison of EGF– and scFv–adapter-mediated EGFR-dependentHSV infection of
HSV-resistant cells. EGFR-positive or -negative CHO-K1 (A, C) and J1.1-2 cells (B, D) were
incubated for 2 h at 37 °Cwith scFv adapter, EGF adapter, or no adapter and a replication-
defective HSV-1 recombinant virus expressing LacZ from the immediate-early ICP0
promoter (QOZHG;MOI=3). Cells were washed after 2 h, incubatedwith freshmedia for
16 h, and examined for LacZ activity by X-gal staining (A, B) or quantitative ONPG assay
(average of triplicate samples) (C, D).
14 K. Nakano et al. / Virology 413 (2011) 12–18methods) demonstrated that virus entry was MOI-dependent and
that the scFv adapter was approximately 15-fold more effective than
the EGF adapter at MOIs where EGF adapter-mediated entry above
background was detectable (Fig. 2C and D).100
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To identify differences between the two adapters that could be
responsible for the difference in their entry-mediating efﬁciencies, we
examined the binding of the adapters to the EGFR and HSV-1 gD
expressed on separate CHO cell lines (CHO-EGFR and CHO-gD,
respectively). The cells were incubated for 90 min at 4 °C with the
same adapter concentrations as used in the entry assays and immuno-
ﬂuorescent staining was performed with an antibody directed against
the c-Myc tag. Flow cytometry demonstrated similar binding of the two
adapters to CHO-EGFR cells (Fig. 3A), but greater binding of the scFv
adapter than the EGF adapter to CHO-gD cells (Fig. 3B).While surprising
since both adapters had the same gD recognition domain, this result
indicated that the afﬁnity of the scFv adapter for gDwas higher than that
of the EGF adapter, possibly due to differential effects of the EGFR-
recognition component of the adapters on the refolding efﬁciency of the
bacterially produced proteins or the refolded conformation of the nectin
portion.Given this bindingdifference,we abandoned theEGF adapter for
the remainder of this study except where used as a negative control.Fig. 3. Adapter binding to EGFR and HSV gD. CHO-EGFR (A) and CHO-gD cells (B) were
incubated at 4 °C with or without adapter, washed extensively, and examined by ﬂow
cytometry with anti-c-Myc tag monoclonal antibody (mAb). Light-blue, EGF adapter;
orange, scFv adapter.Mechanism of adapter-mediated virus entry
To determine the pathway of scFv adapter-mediated entry, we ﬁrst
tested the sensitivityof virus infection to lysosomotropic agents thatblock
endosome acidiﬁcation. On pre-treatment of CHO-EGFR or J-EGFR cells
with ammonium chloride or baﬁlomycin A1 (BFLA), dose-dependent
inhibition of adapter-mediated QOZHG infection was observed (Fig. 4A).
We used a relatively low MOI to avoid potential artifacts due to
overloading of the cells and removed the drugs at 2 h post-infection to
avoid drug-associated toxicity. These conditions precluded deﬁnitive
determination whether all infection involved virus passage through
acidiﬁed endosomes or whether some degree of entry (20–25% based on
the BFLA results) might take place by a pH-independent pathway.
We next examined whether scFv adapter-mediated virus entry
involved clathrin-coated pits, caveolae, or macropinocytosis. Dose-
dependent decreases in infection were observed on J-EGFR and, lessµMµM
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Fig. 4. Sensitivity of scFv-mediated infection of CHO-EGFR and J-EGFR cells to endocytic
pathway inhibitors. (A) Sensitivity to inhibitors of endosome acidiﬁcation. Cells were pre-
incubated with increasing concentrations of ammonium chloride or baﬁlomycin A1 for
30 minand infectedwithQOZHG(MOI=3)plus scFvadapter in the continuedpresenceof
inhibitor for 2 h at 37 °C. The media was replaced and the cells were harvested for ONPG
assay 16 h later. (B) Sensitivity to inhibitors of endocytic uptake. Cells were tested with
sucrose and dansylcadaverine for clathrin-dependent uptake, ﬁlipin for caveolar uptake,
and amiloride and cytochalasin D for macropinocytosis. Conditions were as in (A). Values
are averages of triplicate infections.
15K. Nakano et al. / Virology 413 (2011) 12–18pronounced, CHO-EGFR cells treated with sucrose or dansylcadaverine
(inhibitors of clathrin-dependent uptake) or with amiloride or cytocha-
lasin D (inhibitors of micropinocytosis) (Mercer and Helenius, 2009),
whereas ﬁlipin had a small, dose-independent effect (Fig. 4B). These
results suggested that scFv adapter-mediated virus entry into both cell
lines occurred at least in part by clathrin-dependent endocytosis, the
dominant mechanism of ligand-induced EGFR internalization, and
macropinocytosis, a clathrin-independent mechanism observed at high
EGF and/or EGFR levels (Sorkin and Goh, 2008). The consistently smaller
effects of the different inhibitors on CHO-EGFR than on J-EGFR cells may
be due to differences between the two lines in their uptake or
intracellular clearance of the inhibitory agents. We did not test
combinations of the different drugs due to increased toxicity at the
effective concentrations of the individual drugs. Moreover, we note that
Mercer and Helenius (2009) list additional criteria for macropinocytosis
that have not been examined here.
Transmission electronmicroscopywasperformed on cells incubated
for 15 or 30 min at 37 °C following virus adsorption. At 15 min, we saw
virions in cytoplasmic vesicles of CHO-EGFR cells in the presence of the
scFv adapter, some intimately associated with the vesicle membrane
(Fig. 5A, large arrows) but obtained no evidence of fusion at the cellFig. 5. Ultrastructural analysis of adapter-mediated HSV entry into CHO-EGFR and J-EGFR cel
followed by 15 or 30 min at 37 °C. After ﬁxation, embedding, and staining with uranyl acetate
CHO-EGFR cells at 15 (A, B) or 30 (C) min of incubation with QOZHG and scFv adapter. Large
minute incubation of J-EGFR cells with QOZHG and scFv adapter. (E) CHO-EGFR and (F) J-EG
virions in multivesicular structures and endosome-like vesicles.surface. In addition, capsids could be distinguished in the perinuclear
area (Fig. 5A and B, small arrows). At 30 min, more capsids were
observed near the nucleus along with an occasional large cytoplasmic
vesicle containing deformed virions not clearly associated with the
vesicle membrane (Fig. 5C). Particles in the process of fusing with the
vesicle membrane were seen at 30 min in J-EGFR cells (Fig. 5D), but no
clear examples were captured in CHO-EGFR cells, perhaps indicating
that this is a rapid event in CHO-EGFR cells. These ﬁndings were
consistent with endocytic HSV uptake by both cell lines in the presence
of the scFv adapter and subsequent capsid release into the cytoplasm.
The presence of degrading virions in large vesicles at 30 min in CHO-
EGFR cells may suggest that some virus particles may have been
insufﬁciently complexed with the adapter to escape from endosomes,
similar to the reported fate of HSV incubated with receptor-deﬁcient
CHO cells (Nicola et al., 2003). In addition, it is possible that some of
these particles represented endocytosed defective virions present in the
vector stock. As expected, infection in the presence of the EGF adapter
showed no evidence of cytoplasmic capsids or membrane fusion in
CHO-EGFR and J-EGFR cells at 15 min (data not shown) or 30 min
(Fig. 5E and F). Intact and degrading virus particles were observed in
vesicles, consistent with endosomal uptake without subsequent fusion-ls. Cells were incubated with QOZHG (MOI=10) plus scFv or EGF adapter at 4 °C for 1 h
and lead citrate, the samples were observed under a transmission electron microscope.
arrows, virions in vesicles; small arrows, viral capsids in the perinuclear area. (D) Thirty
FR cells at 30 min incubation with QOZHG and EGF adapter. Arrows point to degrading
16 K. Nakano et al. / Virology 413 (2011) 12–18mediated release. Together, these observations indicated that the scFv
adapter enabled envelope fusionwith theendosomalmembrane in both
CHO-EGFR and J-EGFR cells to deliver capsids into the cytoplasm,
whereas the EGF adapter lacked this ability most likely as a result of its
reduced association with virion gD.
Adapter-mediated infection in vivo
Since adapters are readily re-engineered, they may provide a
ﬂexible method to introduce replication-defective HSV gene transfer
vectors into speciﬁc cell populations in vivo as a means to study these
cells in their natural environment. We assessed the feasibility of this
approach using a tumor model since tumors represent a relatively
homogeneous population of target cells. In vitro infection assays
showed that the scFv adapter augmented QOZHG infection of EGFR-
overexpresssing U-87MG glioblastoma cells, but not of control MCF-7
breast cancer cells that express low levels of the receptor (Reilly and
Gariepy, 1998) (Fig. 6A and B), indicating that the scFv adapter can
increase infection of cells that express both HSV receptors and EGFR.Fig. 6. The scFv adapter mediates increased infection of EGFR-overexpressing tumor
cells in vitro and tumors in vivo. (A) Representative eGFP expression in U-87MG
glioblastoma and MCF-7 breast cancer cells at 16 h post infection with QOZHG
(MOI=3) in the presence (+) or absence (−) of the scFv adapter. (B) QOZHG infection
of U-87MG andMCF-7 cells atMOIs of 0.5–2with orwithout scFv adapterwasmeasured
by ONPG assay. The results of triplicate infections are expressed as the ratios of the
average ONPG readingswith andwithout adapter. (C) A total of 5×106 A549 lung tumor
cellswere implanted in theﬂanks of BALB/c nudemice. Tumorswere grown to ~8 mm in
diameter and injected with 1×107 pfu of QOZHG virus in the presence or absence of
25 μg scFv adapter. Two days later, tumors were surgically removed and processed for
GFP detection and DAPI nuclear staining. Each section is from a different animal treated
with virus plus adapter (panels 1, 2) or virus alone (panels 3, 4). Scale bars: 100 μm.We then used EGFR-overexpressing, HSV-susceptible A549 cells to
form subcutaneous tumors and assessed infection 2 days after
intratumoral injection of QOZHG with or without adapter. The results
demonstrated widespread GFP ﬂuorescence in the presence of the
adapter compared to limited ﬂuorescence in its absence (Fig. 6C),
suggesting that the scFv adapter can be used to enhance HSV-
mediated gene delivery to targeted cell populations even if the target
cells express authentic HSV entry receptors. While our data do not
show infection exclusively through the targeted receptor, they
suggest that this may be achievable with suitable modiﬁcations to
the vector and/or adapter, as recently discussed (Baek et al., 2011).
Discussion
HSV infection has long been considered to occur exclusively via
pH-independent viral envelope fusion with the plasma membrane
(Spear, 1993). However, several reports in the past few years have
demonstrated that the virus can use other mechanisms to gain entry
into cells. Nicola et al. (2003) ﬁrst presented evidence of pH-
dependent endocytic HSV entry into HeLa cells and CHO cells
modiﬁed to express human nectin-1 or HVEM. Subsequently, pH-
independent endocytic infection was described for murine melanoma
cells expressing human nectin-1 (Milne et al., 2005). It has been
suggested that endocytic virus uptake by keratinocytes, HeLa and CHO
cells involves macropinocytosis (Mercer and Helenius, 2009; Nicola
et al., 2005), while evidence of a phagocytosis-like mechanism has
been reported for both CHO-nectin-1 and corneal ﬁbroblast cells
(Clement et al., 2006). In all of these instances, interaction of HSV gD
with an entry receptor is essential for membrane fusion resulting in
viral capsid delivery to the cytoplasm.
Taking advantage of this understanding of the central role of gD and
its receptors in HSV entry, several strategies have been pursued to
enable HSV infection via alternate receptors. One strategy involves virus
engineering to abolish gD recognition of its natural receptors (detarget-
ing) and incorporate a new ligand into gD for interaction with the new
target receptor (retargeting) (Menotti et al., 2009; Zhou and Roizman,
2006). A second strategy does not require virus re-engineering but
instead employs bi-speciﬁc adapters that can function as an attachment
bridge for the virus to the target receptor; without modiﬁcations (van
Beusechemet al., 2003;Verheije et al., 2006), thismethod is restricted to
a single round of virus entry and is therefore primarily useful for
targeted transgene delivery by replication-defective vectors.
We previously demonstrated that an EGFR-speciﬁc adapter
employing the gD-binding V domain of nectin-1 and an anti-EGFR
scFv was effective in mediating virus infection through the EGFR
(Nakano et al., 2005). In the present study, we explored the cellular
pathway utilized by the virus for entry via this adapter and
determined whether an alternate adapter designed to target the
same receptor through a natural ligand could be effective as well.
Although EGFR recognition was similar between the scFv and EGF
adapters, we found that the EGF adapter was much less effective in
mediating virus infection likely because of its weak binding to viral gD
limiting stable virus-adapter complex formation; without stably
bound adapter, internalized virions were expected to remain trapped
in endosomes as previously reported (Nicola and Straus, 2004) and
observed here. In contrast, we propose that stable association of the
scFv adapter with the targeted receptor and viral gD resulted in
endocytic co-internalization of the complex allowing membrane
fusion in acidifying endosomes and capsid release into the cytoplasm.
This suggestion is based on the evidence that scFv adapter-mediated
entry involves low pH-dependent endocytosis along with our
previous observation that the process requires binding of the adapter
to both the targeted receptor and viral gD (Nakano et al., 2005).
We previously reported that the V domain of nectin-1 can mediate
efﬁcient HSV entry as a soluble molecule not anchored in or attached
to the cell membrane (Kwon et al., 2006). In addition, we showed that
17K. Nakano et al. / Virology 413 (2011) 12–18virion attachment to cell-surface proteoglycans is essential in this
instance. Our experiments in the present study allowed for virus
attachment to proteoglycans, raising the question why adapter-
mediated infection required a gD receptor. It is possible that the
conformation of the nectin-1 portion of the receptor is altered by its
fusion to the scFv region, precluding gD activation without additional
changes induced by EGFR binding and an acidic environment. The
reduced gD binding activity of the EGF adapter is consistent with the
suggestion that the conformation of the nectin-1V domain is sensitive
to C-terminal additions, as also suggested by our previous ﬁnding that
the soluble V domain blocks HSV infection of nectin-1 expressing cells
while the scFv adapter does not (Nakano et al., 2005).
The evidence presented in this study that the scFv adapter was able
to increase the areaof infection in the relatively homogeneous target cell
population provided by a tumor supports the feasibility of using
adapters for HSV-mediated gene transfer to speciﬁc populations of cells
in vivo, such as neuronal subtypes in the brain that can be differentially
targeted based on their unique receptor proﬁles (Anliker et al., 2010).
This would involve the use of replication-defective vectors like QOZHG
that enter a latent-like state upon infection, leaving cellular gene
expression essentially unaltered while allowing short- or long-term
transgene expression fromdifferentpromoters (Craft et al., 2008;Krisky
et al., 1998; Puskovic et al., 2004; Wu et al., 1996). Such a system could
be used to label speciﬁc cell populations with reporter genes and/or to
examine the effect of adding or blocking certain gene functions
exclusively in these cells. Our current adapters rely on the ability of
gD to bind to either nectin-1 (Nakano et al., 2005) or HVEM (Baek et al.,
2011) and can be used in combination with our recently described
nectin-1- or HVEM-restricted mutant vectors (Uchida et al., 2009) to
reduce infection through the natural HSV receptors present on a broad
range of cells. Ultimately, adapter–vector pairs can be designed that no
longer require gD binding to one of its cognate receptors and such
combinations will allow virus entry exclusively via the targeted
receptor. Adapters provide greater ﬂexibility than currently described
retargeted HSV vectors since adapter speciﬁcity can be readily changed
by incorporation of a different scFv (Baek et al., 2011) while the ground
rules for efﬁcient HSV retargeting via ligand or scFv incorporation into
gD remain to be ﬁrmly established. Adapters may therefore be a
practical and broadly applicable tool to study andmodify the function of
speciﬁc cells in mixed cell populations.
Materials and methods
Cell lines
Chinese hamster ovary cells (CHO-K1, ATCC, CCL-61) were
maintained in Ham's F12K medium (Gibco-Invitrogen, Carlsbad, CA)
with 10% fetal bovine serum (FBS), 100 U/ml penicillin and 100 μg/ml
streptomycin (Gibco-Invitrogen). CHO-gD (Kwon et al., 2006) and
CHO-EGFR (a kind gift from H. Ebina, Tokushima University, Japan)
are CHO-K1 derivatives constitutively expressing HSV-1 gD and the
human EGFR, respectively. Both cell lines were grown in the above
medium containing 400 μg/ml G418 (Gibco-Invitrogen). HSV-1-resis-
tant J1.1-2 cells (kindly provided by G. Campadelli-Fiume, Bologna,
Italy) were grown in Dulbecco's MEM (Gibco-Invitrogen) containing
10% FBS, 100 U/ml penicillin and 100 μg/ml streptomycin. J-EGFR cells
were generated by transfection of J1.1-2 cells with a human EGFR
expression plasmid (EGFR/pCx5 ori, a gift from I. Pastan, NIH,
Bethesda, MD) and cloning of G418-resistant cells. Human lung
cancer A549, glioblastoma U-87MG, and breast cancer MCF-7 cells
were purchased from ATCC (Manassas, VA).
Virus
QOZHG is a replication-defective derivative of HSV-1 strain KOS
(Chen et al., 2000). Brieﬂy, QOZHG is deleted for the immediate early(IE or α) genes ICP4 and ICP27 and expresses the ICP22 and ICP47 IE
genes from early (E or β) promoters. The virus contains an expression
cassette for bacterial β-galactosidase in the UL41 locus and for
enhanced green ﬂuorescent protein (eGFP) in UL54 (ICP27). QOZHG
was grown and titered on ICP4/ICP27-complementing 7b cells (Krisky
et al., 1997).
Adapter proteins
Plasmid constructs
The bacterial expression construct pRA-V-528LH for production of
the scFv adapter was previously described (Nakano et al., 2005). An
expression construct for the EGF adapter, termed pRA-V-EGF, was
derived from pRA-V-528LH by replacing the XhoI-SacII fragment
spanning the scFv region with the complete EGF open reading frame
(Fig. 1A). The EGF fragment was obtained by PCR using a human
EGF cDNA plasmid (kindly provided by I. Dmitriev, University of
Alabama) as template and a pair of primers that added a XhoI site
immediately upstream of the open reading frame and a SacII site
immediately downstream. The primer sequences were as follows:
forward, 5′-GGGGCT CGAGAATAGTGACTCTGAATGTCCCCTGTCC-3′; re-
verse, 5′-CTGCAGCCGCGGAGCGCAGTTCCCACCACTTCAGGTCTCG-3′.
Production of adapter proteins
Adapter proteins were produced as previously described (Nakano
et al., 2005). Brieﬂy, Echerichia coli BL21 (DE3) cells were transformed
with pRA-V-EGF or pRA-V-528LH and grown at 28 °C in 2xYT broth
supplemented with 100 μg/ml ampicillin. Expression of recombinant
proteins (EGF– or scFv–adapter, respectively) was induced by
addition of 1 mM isopropyl-1-thio-β-D-galactopyranoside (IPTG).
After overnight culture, bacterial pellets were collected by centrifu-
gation (2000g, 35 min) and solubilized with 10 ml of 6 M guanidi-
nium hydrochloride (Sigma-Aldrich, St. Louis, MO) in PBS (Gu-HCl/
PBS) overnight at 4 °C. Protein samples were puriﬁed on a 2 ml TALON
metal afﬁnity column (Clontech, Palo Alto, CA) by elution with Gu-
HCl/PBS containing 250 mM imidazole. The recovered protein was
refolded by sequential dialysis against Gu-HCl/PBS and PBS (pH 7.9),
centrifuged at 4500g for 20 min at 4 °C, and sterilized by ﬁltration
through a 0.22 μm ultraﬁltration membrane (Millipore, Tokyo, Japan).
HSV-1 entry assays
Cells were grown to conﬂuence in 96-well plates (5×104 cells/well)
in medium containing 10% FBS. QOZHG virus and adapters were
inoculated with the cells in 40 μl of serum-free medium for 2 h at
37 °C. The cells were washed once with PBS, overlaid with fresh 10% FBS
medium, and incubated for 16 h at 37 °C. Entry was evaluated as
previously described (Nakano et al., 2005), including (i) visual inspection
of monolayers for GFP reporter gene expression under a ﬂuorescent
microscope; (ii) staining of ﬁxed cultures with β-galactosidase colori-
metric substrate, 5-bromo-4-chloro-3-indolyl-β-D-galactopyranoside
(X-gal, 0.2 mg/ml; Sigma-Aldrich); or (iii) ONPG assay to determine
β-galactosidase levels in triplicate-infected cultures. ONPG assays
involved cell lysis in 150 μl of 1% NP-40, 1 mM MgCl2, 50 mM β-
mercaptoethanol and4 mg/mlβ-galactosidase substrate o-nitrophenyl-
β-D-galactopyranoside (ONPG; Sigma-Aldrich), incubation at 37 °C for
15–20 min until a faint yellow color developed, and measurement of
absorbance at 405 nm.
Effect of blocking agents on adapter-mediated infection
Stock solutions of ammonium chloride, baﬁlomycin A1, amiloride,
cytochalasin D, dansylcadaverine (all from Sigma-Aldrich), sucrose,
and ﬁlipin (WAKO, Osaka, Japan) were prepared in de-ionized water
or ethanol and adjusted to pH 7.4 just before use. Cells were pre-
incubated in F12K or DMEM media in triplicate with different
18 K. Nakano et al. / Virology 413 (2011) 12–18concentrations of the drugs or sucrose for 30 min, infected with
QOZHG (MOI=3) and scFv adapter for 2 h in the continued presence
of the inhibitor, cultured in fresh media for 16 h, and examined for
HSV entry by ONPG assay.
Transmission electron microscopy
QOZHG (MOI=10) and adapters (30 μg/ml) were adsorbed to
cells at 4 °C for 1 h and entry was initiated by raising the temperature
to 37 °C for 0–30 min, as above. The cells were then washed with cold
phosphate buffer (pH 7.2) and ﬁxed with 2.5% glutaraldehyde/1%
osmium tetraoxide. Samples were embedded in epoxy resin (Oken,
Japan) and ultra thin sections (70 nm) were double stained with
uranyl acetate and lead citrate for observation under a transmission
electron microscope (H-7000, Hitachi, Japan) (Ishikawa et al., 2006).
Flow cytometry
To compare the afﬁnities of the scFv and EGF adapters for EGFR or
HSV-gD, the adapters (30 μg/ml in F12K/HEPES buffer) were adsorbed
to cells expressing EGFR or gD (2×105 cells/24-well plate) at 4 °C for
1 h. The cells were washed, re-suspended in PBS, and incubated with
anti-c-Myc antibody at 4 °C for 1 h and secondary PE-conjugated anti-
mouse IgG for 30 min. After washing with BD FACSFlow solution (BD
Biosciences Pharmingen), adapter binding to the cells was evaluated
by BD FACSCalibur ﬂow cytometry.
Tumor infection in vivo
EGFR-overexpressing A549 lung cancer cells (5×106 cells/animal)
were implanted in the ﬂanks of BALB/c nude mice. When tumors
reached a diameter of approximately 8 mm, QOZHG virus (1×107 pfu)
was injected intratumorally with or without scFv adapter at 25 μg/
100 μl. Two days later, tumors were surgically removed and stored at
−80 °C. Tissue sections (12 μm thickness) were prepared by cryostat
and processed for DAPI (Invitrogen) staining and detection of GFP
ﬂuorescence to visualize the extent of infection.
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